10-Amino-1MQ: The Small Molecule Scientists Are Studying for Metabolic Support

What is 10-Amino-1MQ?

10-Amino-1MQ is a small molecule (not a peptide) that belongs to the class of NNMT (nicotinamide N-methyltransferase) inhibitors. Unlike most peptides, it has a low molecular weight and a different mechanism of action.

NNMT is an enzyme that plays a key role in the energy metabolism of cells. When its activity is too high, this can lead to fat tissue accumulation and slowed metabolism — at least according to the preclinical models studied so far.

The molecule was first synthesized in university laboratories and is the subject of intensive research in the context of metabolic syndrome.

How does it act at the cellular level?

10-Amino-1MQ inhibits the NNMT enzyme, which leads to an increase in intracellular NAD+ levels — a critical cofactor for hundreds of metabolic reactions in the body.

When NAD+ levels rise, cells can produce energy more efficiently. In preclinical models (mice), this has manifested as increased fat burning and improved insulin sensitivity.

It is important to note that all data to date come from animal models. Human clinical trials have not yet been published.

What does the research say?

A 2020 study published in Biochemical Pharmacology demonstrated that inhibiting NNMT in mice on a high-fat diet led to a significant reduction in fat tissue without changes in diet or physical activity.

Researchers from the University of Texas Health Science Center found that 10-Amino-1MQ increases cellular NAD+ levels, which improves mitochondrial function — the main 'engine' of cellular energy.

Despite the promising preclinical results, scientists emphasize that human trials are needed to confirm these effects.

5 reasons why 10-Amino-1MQ is attracting scientific interest

1. Unique mechanism — Unlike most metabolism supplements, 10-Amino-1MQ acts through NNMT inhibition rather than through stimulants or thermogenic substances. This is a fundamentally different approach.

2. NAD+ boosting — Increasing NAD+ levels is associated with improved cellular energy, better mitochondrial function, and potential antioxidant effects.

3. Not a peptide — As a small molecule, 10-Amino-1MQ has different pharmacokinetics than peptides. This means potentially easier absorption and a more stable structure.

4. Complements other approaches — In a research context, 10-Amino-1MQ is being studied in combination with GLP-1 agonists and other metabolic peptides for a potential synergistic effect.

5. Growing body of research — Since 2018, publications on NNMT inhibitors have grown exponentially, reflecting the serious scientific interest in this target.

Quality and purity

Peptolux offers 10-Amino-1MQ with purity ≥98%, confirmed via HPLC analysis. Each batch comes with a certificate of analysis (CoA) with a unique batch number.

The product is manufactured in EU-certified laboratories following ISO and GMP standards. Store at +2°C to +8°C for maximum stability.

Frequently Asked Questions

What is the difference between 10-Amino-1MQ and metabolism peptides? — 10-Amino-1MQ is a small molecule, not a peptide. It acts through a different mechanism (NNMT inhibition) and can be combined with peptides such as Semaglutide or MOTS-c to study synergistic effects.

Is there human clinical data? — At present, there are no published randomized controlled trials in humans. All data come from preclinical (in vitro and animal) models.

How should it be stored? — Store at +2°C to +8°C (refrigerated). Do not freeze. Keep away from direct sunlight.

This article is for informational purposes only and does not constitute medical advice. The products mentioned in it are intended for scientific and research purposes. Consult a qualified professional before any use. Individual results may vary.